Valuation: Compumedics Limited

Market Cap 44.95M 31.45M 27.32M 25.48M 23.4M 44.17M 3B 301M 118M 1.5B 118M 116M 4.95B P/E 2026 *
15x
P/E 2027 * 6.08x
Enterprise Value 44.95M 31.45M 27.32M 25.48M 23.4M 44.17M 3B 301M 118M 1.5B 118M 116M 4.95B EV / Sales 2026 *
0.68x
EV / Sales 2027 * 0.56x
Free-Float
36.04%
Yield 2026 *
-
Yield 2027 * 8.89%
1 day+2.27%
1 week-2.17%
1 month-10.00%
3 months-20.35%
6 months-43.75%
Current year-32.84%
1 week 0.22
Extreme 0.215
0.24
1 month 0.22
Extreme 0.215
0.3
Current year 0.22
Extreme 0.215
0.45
1 year 0.22
Extreme 0.215
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.49
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 15/12/2010
Director of Finance/CFO 61 10/11/2009
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 15/12/2010
Director/Board Member 61 31/12/1999
Director/Board Member - 26/10/2022
Change 5-day change 1-year change 3-year change Capi.($)
+2.27%-2.17%-36.62%+36.36% 31.55M
-0.05%+1.02%+23.97%+3.66% 212B
+1.29%+3.13%+0.21%-23.41% 137B
+6.25%+11.23%-22.29%+19.61% 125B
+3.64%+9.45%-54.06%-4.33% 69.46B
+3.20%+7.49%+11.96%+10.50% 49.56B
+6.10%+11.55%-15.77%-20.80% 47.2B
+1.03%+0.89%+23.17%+9.47% 39.08B
-0.68%+0.02%+29.08%+28.44% 37.05B
-3.38%+2.10%+109.34%+4.54% 30.97B
Average +1.00%+2.87%+6.90%+6.40% 74.76B
Weighted average by Cap. +0.71%+2.80%+5.08%+1.10%

Financials

2026 *2027 *
Net sales 66.3M 46.39M 40.3M 37.59M 34.52M 65.16M 4.42B 443M 174M 2.21B 174M 170M 7.3B 79.7M 55.77M 48.45M 45.19M 41.49M 78.33M 5.32B 533M 209M 2.65B 209M 205M 8.78B
Net income 3.8M 2.66M 2.31M 2.15M 1.98M 3.73M 253M 25.41M 9.96M 126M 9.99M 9.77M 419M 9M 6.3M 5.47M 5.1M 4.69M 8.85M 600M 60.17M 23.59M 300M 23.65M 23.13M 991M
Net Debt - -
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
31/07/26 A$0.2250 +2.27% 5,811
29/07/26 A$0.2200 -8.33% 25,561
28/07/26 A$0.2400 -.--% 4,166
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2250AUD
Average target price
0.8000AUD
Spread / Average Target
+255.56%

Annual profits - Rate of surprise